Publication | Closed Access

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

Autoimmune DiseaseInsulin ManagementDiabetesImmunologyT-regulatory CellAutoimmunityOkt3 MabPhase IiaImmunotherapyMedicineAlleviates Insulin ResistanceInsulin Signaling